Small AI companion sites, many run by solo developers, are using emotional attachment tactics to turn intimacy into income. Young users are entering lightly moderated spaces where harmful characters ...

Anthropic, the artificial intelligence company behind the Claude chatbot, said Monday it has confidentially filed for an initial public offering. The move catapults Anthropic ahead of its rival OpenAI ...

OpenAI plans to roll out a revamped version of ChatGPT in the coming weeks — one that will serve as a “super app” with coding tools and AI agents, according to Financial Times. The company’s goal is ...

ChatGPT started the AI revolution, but it isn't the only chatbot worth using. We've tested the top AI chatbots to help you determine which one is right for you. I’ve been writing about consumer ...

LEARNER drivers are finally seeing a flood of test slots after a crackdown on the bot operators accused of hoarding appointments and flogging them for profit. Motorists have taken to social media to ...

Microsoft is hosting its developer conference MS Build 2026 on June 2nd and 3rd, 2026. The company is particularly addressing developers who create software for the Windows ecosystem. As in previous ...

A San Francisco robotics startup is being taken to court by an Airbnb host who claims the company’s “robotic prototype testing” caused extensive damage to his home. In the lawsuit filed on May 26, ...

A semiconductor is a basic element or compound substance that conducts electricity in certain situations. AI chatbots like ChatGPT have gotten a ton of attention since OpenAI launched it in Nov. 2022, ...

At Microsoft Build 2026, GitHub introduced a standalone desktop application for its AI assistant Copilot. As the company explains in its announcement, the Copilot app is intended to serve as a central ...

The popular chatbot has become a symbol of the promises, perils, and potential profits of artificial intelligence Nathan Reiff has been writing expert articles and news about financial topics such as ...

The 8th Neuroimmunology Drug Development Summit 2026 is a flagship event for companies advancing therapies at the intersection of neuroscience and immunology. This guide covers emerging targets, ...